chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Bone pain, Chills, Dizziness
Clinical narrative: I was in bed for about four days/I only got up to go to the bathroom; I was also sick to my stomach; I was so sick; very weak; throw up several times; Bones hurt like she´s got the flu; Flu like symptoms; Dizziness; chills; Nausea; got tired; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Bones hurt like she´s got the flu), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), INFLUENZA LIKE ILLNESS (Flu like symptoms) and DIZZINESS (Dizziness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), SPIRONOLACTONE and CALCIUM for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced HEADACHE (Headache). On 17-Feb-2021, the patient experienced BONE PAIN (Bones hurt like she´s got the flu), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizziness), CHILLS (chills), NAUSEA (Nausea), FATIGUE (got tired) and PYREXIA (Fever). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), ILLNESS (I was so sick), ASTHENIA (very weak) and VOMITING (throw up several times). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 dosage form. At the time of the report, BONE PAIN (Bones hurt like she´s got the flu), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizziness), ILLNESS (I was so sick), ASTHENIA (very weak), CHILLS (chills), NAUSEA (Nausea), FATIGUE (got tired), PYREXIA (Fever) and VOMITING (throw up several times) outcome was unknown and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Significant follow up.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Illness, Influenza like illness, Loss of personal independence in daily activities
Clinical narrative: I was in bed for about four days/I only got up to go to the bathroom; I was also sick to my stomach; I was so sick; very weak; throw up several times; Bones hurt like she´s got the flu; Flu like symptoms; Dizziness; chills; Nausea; got tired; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Bones hurt like she´s got the flu), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), INFLUENZA LIKE ILLNESS (Flu like symptoms) and DIZZINESS (Dizziness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), SPIRONOLACTONE and CALCIUM for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced HEADACHE (Headache). On 17-Feb-2021, the patient experienced BONE PAIN (Bones hurt like she´s got the flu), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizziness), CHILLS (chills), NAUSEA (Nausea), FATIGUE (got tired) and PYREXIA (Fever). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), ILLNESS (I was so sick), ASTHENIA (very weak) and VOMITING (throw up several times). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 dosage form. At the time of the report, BONE PAIN (Bones hurt like she´s got the flu), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizziness), ILLNESS (I was so sick), ASTHENIA (very weak), CHILLS (chills), NAUSEA (Nausea), FATIGUE (got tired), PYREXIA (Fever) and VOMITING (throw up several times) outcome was unknown and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Significant follow up.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: I was in bed for about four days/I only got up to go to the bathroom; I was also sick to my stomach; I was so sick; very weak; throw up several times; Bones hurt like she´s got the flu; Flu like symptoms; Dizziness; chills; Nausea; got tired; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Bones hurt like she´s got the flu), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), INFLUENZA LIKE ILLNESS (Flu like symptoms) and DIZZINESS (Dizziness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), SPIRONOLACTONE and CALCIUM for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced HEADACHE (Headache). On 17-Feb-2021, the patient experienced BONE PAIN (Bones hurt like she´s got the flu), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizziness), CHILLS (chills), NAUSEA (Nausea), FATIGUE (got tired) and PYREXIA (Fever). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), ILLNESS (I was so sick), ASTHENIA (very weak) and VOMITING (throw up several times). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 dosage form. At the time of the report, BONE PAIN (Bones hurt like she´s got the flu), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (I was in bed for about four days/I only got up to go to the bathroom), ABDOMINAL DISCOMFORT (I was also sick to my stomach), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (Dizziness), ILLNESS (I was so sick), ASTHENIA (very weak), CHILLS (chills), NAUSEA (Nausea), FATIGUE (got tired), PYREXIA (Fever) and VOMITING (throw up several times) outcome was unknown and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Significant follow up.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Illness, Influenza, Myalgia, Nausea
Clinical narrative: Full on Flu; Body aches; Weak and sick; Weak and sick; Vertigo; Felt like I wanted to throw up; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Full on Flu), MYALGIA (Body aches), ASTHENIA (Weak and sick), ILLNESS (Weak and sick) and VERTIGO (Vertigo) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 154201) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INFLUENZA (Full on Flu), MYALGIA (Body aches), ASTHENIA (Weak and sick), ILLNESS (Weak and sick), VERTIGO (Vertigo) and NAUSEA (Felt like I wanted to throw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Full on Flu; Body aches; Weak and sick; Weak and sick; Vertigo; Felt like I wanted to throw up; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Full on Flu), MYALGIA (Body aches), ASTHENIA (Weak and sick), ILLNESS (Weak and sick) and VERTIGO (Vertigo) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 154201) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INFLUENZA (Full on Flu), MYALGIA (Body aches), ASTHENIA (Weak and sick), ILLNESS (Weak and sick), VERTIGO (Vertigo) and NAUSEA (Felt like I wanted to throw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dizziness, Dyspnoea, Fatigue
Clinical narrative: Difficulty breathing; Swelling of face and Throat; Swelling of face and Throat; Loss of appetite; weakness; Tenderness; Pealing and breakage of skin in the same arm of the injection; Dizziness; Rash; Headaches; Body aches; Fatigue; Nausea; Along with pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite) and ASTHENIA (weakness) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (medications are not specified) and Abdominal pain on 01-Mar-2021.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite), ASTHENIA (weakness), TENDERNESS (Tenderness), INJECTION SITE DRYNESS (Pealing and breakage of skin in the same arm of the injection), DIZZINESS (Dizziness), RASH (Rash), HEADACHE (Headaches), MYALGIA (Body aches), FATIGUE (Fatigue), NAUSEA (Nausea) and INJECTION SITE PAIN (Along with pain). At the time of the report, DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite), ASTHENIA (weakness), TENDERNESS (Tenderness), INJECTION SITE DRYNESS (Pealing and breakage of skin in the same arm of the injection), DIZZINESS (Dizziness), RASH (Rash), HEADACHE (Headaches), MYALGIA (Body aches), FATIGUE (Fatigue), NAUSEA (Nausea) and INJECTION SITE PAIN (Along with pain) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-215431 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up included date of birth, height and weight, and first and second dose information.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site dryness, Injection site pain, Myalgia, Nausea
Clinical narrative: Difficulty breathing; Swelling of face and Throat; Swelling of face and Throat; Loss of appetite; weakness; Tenderness; Pealing and breakage of skin in the same arm of the injection; Dizziness; Rash; Headaches; Body aches; Fatigue; Nausea; Along with pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite) and ASTHENIA (weakness) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (medications are not specified) and Abdominal pain on 01-Mar-2021.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite), ASTHENIA (weakness), TENDERNESS (Tenderness), INJECTION SITE DRYNESS (Pealing and breakage of skin in the same arm of the injection), DIZZINESS (Dizziness), RASH (Rash), HEADACHE (Headaches), MYALGIA (Body aches), FATIGUE (Fatigue), NAUSEA (Nausea) and INJECTION SITE PAIN (Along with pain). At the time of the report, DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite), ASTHENIA (weakness), TENDERNESS (Tenderness), INJECTION SITE DRYNESS (Pealing and breakage of skin in the same arm of the injection), DIZZINESS (Dizziness), RASH (Rash), HEADACHE (Headaches), MYALGIA (Body aches), FATIGUE (Fatigue), NAUSEA (Nausea) and INJECTION SITE PAIN (Along with pain) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-215431 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up included date of birth, height and weight, and first and second dose information.
Sex: M
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Rash, Swelling face, Tenderness
Clinical narrative: Difficulty breathing; Swelling of face and Throat; Swelling of face and Throat; Loss of appetite; weakness; Tenderness; Pealing and breakage of skin in the same arm of the injection; Dizziness; Rash; Headaches; Body aches; Fatigue; Nausea; Along with pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite) and ASTHENIA (weakness) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (medications are not specified) and Abdominal pain on 01-Mar-2021.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite), ASTHENIA (weakness), TENDERNESS (Tenderness), INJECTION SITE DRYNESS (Pealing and breakage of skin in the same arm of the injection), DIZZINESS (Dizziness), RASH (Rash), HEADACHE (Headaches), MYALGIA (Body aches), FATIGUE (Fatigue), NAUSEA (Nausea) and INJECTION SITE PAIN (Along with pain). At the time of the report, DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite), ASTHENIA (weakness), TENDERNESS (Tenderness), INJECTION SITE DRYNESS (Pealing and breakage of skin in the same arm of the injection), DIZZINESS (Dizziness), RASH (Rash), HEADACHE (Headaches), MYALGIA (Body aches), FATIGUE (Fatigue), NAUSEA (Nausea) and INJECTION SITE PAIN (Along with pain) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-215431 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up included date of birth, height and weight, and first and second dose information.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Fatigue, Malaise, Vomiting
Clinical narrative: pretty sick - down for three days; vomiting pretty severely; diarrhea pretty severely; some feeling of fatigue; Joint Soreness; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (pretty sick - down for three days), VOMITING (vomiting pretty severely), DIARRHOEA (diarrhea pretty severely), FATIGUE (some feeling of fatigue) and ARTHRALGIA (Joint Soreness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced VOMITING (vomiting pretty severely), DIARRHOEA (diarrhea pretty severely), FATIGUE (some feeling of fatigue) and ARTHRALGIA (Joint Soreness). On an unknown date, the patient experienced MALAISE (pretty sick - down for three days). At the time of the report, MALAISE (pretty sick - down for three days), VOMITING (vomiting pretty severely), DIARRHOEA (diarrhea pretty severely), FATIGUE (some feeling of fatigue) and ARTHRALGIA (Joint Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MALAISE (pretty sick - down for three days), VOMITING (vomiting pretty severely), DIARRHOEA (diarrhea pretty severely), FATIGUE (some feeling of fatigue) and ARTHRALGIA (Joint Soreness) to be possibly related.    No concomitant medications or treatment details reported.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive for covid; This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (Tested positive for covid) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for covid). At the time of the report, COVID-19 (Tested positive for covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No other concomitant medication was reported. Treatment information was as Regeneron Covid 19 antibody cocktail.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up received and contains no new information
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Pain, Pain in extremity
Clinical narrative: Arm wont stop hurting; Pain moving from shoulder to neck and pain interfering with sleep; pain interfering with his sleep; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm wont stop hurting), PAIN (Pain moving from shoulder to neck and pain interfering with sleep) and INSOMNIA (pain interfering with his sleep) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001a210) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cholesterol total abnormal NOS.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm wont stop hurting), PAIN (Pain moving from shoulder to neck and pain interfering with sleep) and INSOMNIA (pain interfering with his sleep). At the time of the report, PAIN IN EXTREMITY (Arm wont stop hurting), PAIN (Pain moving from shoulder to neck and pain interfering with sleep) and INSOMNIA (pain interfering with his sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also include : Blood pressure medication and Cholesterol medication
Sex: F
Vaccine: COVID19
Symptoms: Pain, Urticaria
Clinical narrative: breaking out in hives; hurt all over; This spontaneous case was reported by a physician and describes the occurrence of PAIN (hurt all over) and URTICARIA (breaking out in hives) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 043120A) for COVID-19 vaccination.     Concomitant products included METFORMIN for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN (hurt all over). On 07-Mar-2021, the patient experienced URTICARIA (breaking out in hives). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PAIN (hurt all over) and URTICARIA (breaking out in hives) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication also include: Thyroid medication, BP medication, Depression medication and cholesterol medication.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Cognitive disorder, Dizziness, Fatigue, Neuralgia, Pain in extremity
Clinical narrative: Trigeminal pain on the right side of her face; Nerve pain in left arm; Cognitive word findings; Dizziness / light headedness; Fatigue; Arm soreness; A spontaneous report was received from a heath professional concerning a 56-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fatigue, pain in extremity, neuralgia , trigeminal neuralgia, dizziness and cognitive disorder.  The patient's medical history included multiple sclerosis. Concomitant medications were not reported.  On 08 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011L20A) intramuscularly for prophylaxis of COVID-19 infection.   On 5 Feb 2021,  the patient received their second of two planned doses of mRNA-1273 (Lot number: 012M20A) intramuscularly for prophylaxis of COVID-19 infection.   On 06 Feb 2021, the patient experienced mild reactions as fatigue and arm soreness. On 08 Feb 2021, the patient experienced nerve pain in her left arm, trigeminal pain on the right side of her face, dizziness, light headedness and cognitive word findings that are not visible on her multiple sclerosis symptoms.  Patient notified her neurologist and she was intervened with Steroid pack on 15 Feb 2021, that help for a while not until  27Feb. Left arm nerve pain and trigeminal pain  came back on 28 Feb 2021. She was scheduled on another steroid pack last 1 Mar 2021 however, trigeminal pain came back on 6 Mar 2021. If another Steroid pad will not work, she was planning to undergo on different series of blood works.  Action taken with mRNA-1273 in response to the events was not applicable.  The events, fatigue and arm soreness , were considered resolved on 06 Feb 2021.   The events, nerve pain in her left arm, trigeminal pain on the right side of her face, dizziness / light headedness and cognitive word findings, were considered not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events,  a causal relationship cannot be excluded.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Trigeminal neuralgia
Clinical narrative: Trigeminal pain on the right side of her face; Nerve pain in left arm; Cognitive word findings; Dizziness / light headedness; Fatigue; Arm soreness; A spontaneous report was received from a heath professional concerning a 56-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fatigue, pain in extremity, neuralgia , trigeminal neuralgia, dizziness and cognitive disorder.  The patient's medical history included multiple sclerosis. Concomitant medications were not reported.  On 08 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011L20A) intramuscularly for prophylaxis of COVID-19 infection.   On 5 Feb 2021,  the patient received their second of two planned doses of mRNA-1273 (Lot number: 012M20A) intramuscularly for prophylaxis of COVID-19 infection.   On 06 Feb 2021, the patient experienced mild reactions as fatigue and arm soreness. On 08 Feb 2021, the patient experienced nerve pain in her left arm, trigeminal pain on the right side of her face, dizziness, light headedness and cognitive word findings that are not visible on her multiple sclerosis symptoms.  Patient notified her neurologist and she was intervened with Steroid pack on 15 Feb 2021, that help for a while not until  27Feb. Left arm nerve pain and trigeminal pain  came back on 28 Feb 2021. She was scheduled on another steroid pack last 1 Mar 2021 however, trigeminal pain came back on 6 Mar 2021. If another Steroid pad will not work, she was planning to undergo on different series of blood works.  Action taken with mRNA-1273 in response to the events was not applicable.  The events, fatigue and arm soreness , were considered resolved on 06 Feb 2021.   The events, nerve pain in her left arm, trigeminal pain on the right side of her face, dizziness / light headedness and cognitive word findings, were considered not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events,  a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Allergy to antibiotic (The patient have allergy towards Clindamycin.).    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. The treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow up received on 18 Jun 2021 contains Non significant information.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site haemorrhage, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: bleeding  at the injection site; heat at the injection site; itching at injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (bleeding  at the injection site), VACCINATION SITE WARMTH (heat at the injection site), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (bleeding  at the injection site), VACCINATION SITE WARMTH (heat at the injection site), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE HAEMORRHAGE (bleeding  at the injection site), VACCINATION SITE WARMTH (heat at the injection site), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included blood pressure medication.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow-up information was received on 03 May2021, event outcome updated to resolved. patient denied further follow-up.
Sex: F
Vaccine: COVID19
Symptoms: Injection site haemorrhage, Vaccination site discomfort, Vaccination site pain
Clinical narrative: injection site bleeding; discomfort at injection site; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HAEMORRHAGE (injection site bleeding), VACCINATION SITE DISCOMFORT (discomfort at injection site) and VACCINATION SITE PAIN (Vaccination site pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported). Concomitant products included NIFEDIPINE and LOSARTAN for an unknown indication.   On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced INJECTION SITE HAEMORRHAGE (injection site bleeding), VACCINATION SITE DISCOMFORT (discomfort at injection site) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, INJECTION SITE HAEMORRHAGE (injection site bleeding), VACCINATION SITE DISCOMFORT (discomfort at injection site) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.            Treatment medication taken was paracetamol.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: palms, hands and feet were all itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (palms, hands and feet were all itchy) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (palms, hands and feet were all itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Symptomatic treatment, at an unspecified dose and frequency and PREDNISONE for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PRURITUS (palms, hands and feet were all itchy) had not resolved.            Treatment medication also include: Steroid cream
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Migraine
Clinical narrative: 5 migraines a week; Condition aggravated; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (5 migraines a week) and CONDITION AGGRAVATED (Condition aggravated) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Migraine (Patient has a medical history of 40 years of migraines.). Concomitant products included BOTULINUM TOXIN TYPE A (BOTOX) for Migraine.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced MIGRAINE (5 migraines a week) and CONDITION AGGRAVATED (Condition aggravated). At the time of the report, MIGRAINE (5 migraines a week) and CONDITION AGGRAVATED (Condition aggravated) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow up received on 09 Jul 2021 with event outcome updated and new event added.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: diarrhea; Muscle pain; nausea; headache; fever; A spontaneous report ( was received from a consumer concerning a 61-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events muscle pain, nausea, diarrhea, headache, fever.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 27 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 001A210A) intramuscularly for prophylaxis of COVID-19 infection.  On 28 Feb 2021, the patient experienced the event(s) muscle pain, nausea, diarrhea, headache, fever.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), muscle pain, nausea, diarrhea, headache, fever was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Sinusitis
Clinical narrative: Sinus infection; Cough; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection) and COUGH (Cough) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced SINUSITIS (Sinus infection) and COUGH (Cough). At the time of the report, SINUSITIS (Sinus infection) and COUGH (Cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, COVID-19: positive (Inconclusive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain
Clinical narrative: Painful Lymph node under arm; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events painful lymph node under arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 5 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) Painful Lymph node under arm.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), painful lymph node under arm was unknown.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives). At the time of the report, URTICARIA (hives) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not provided. Concomitant medication not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: TCR with update on outcome, Reporter denied further Follow-up
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.    This case was linked to MOD-2021-036812, MOD-2021-036813, MOD-2021-036769 (E2B Linked Report).; Sender's Comments:  MOD-2021-036813:same reporter, reporter's husband MOD-2021-036769:same reporter, reporter's husband's daughter MOD-2021-036812:same reporter, invalid case
Sex: U
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: Doses administered by pooling vials; got 12 or 13 doses from each vial; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Doses administered by pooling vials; got 12 or 13 doses from each vial) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Doses administered by pooling vials; got 12 or 13 doses from each vial). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Doses administered by pooling vials; got 12 or 13 doses from each vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.; Sender's Comments: This report refers to a case of wrong technique in product usage process for mRNA-1273.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Limb discomfort, Productive cough, Vaccination site swelling
Clinical narrative: Phlegm; Arm Soreness; had a raised area that was quite large; Energy levels have decreased; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (Phlegm), LIMB DISCOMFORT (Arm Soreness), VACCINATION SITE SWELLING (had a raised area that was quite large) and FATIGUE (Energy levels have decreased) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCTIVE COUGH (Phlegm), LIMB DISCOMFORT (Arm Soreness), VACCINATION SITE SWELLING (had a raised area that was quite large) and FATIGUE (Energy levels have decreased). At the time of the report, PRODUCTIVE COUGH (Phlegm), LIMB DISCOMFORT (Arm Soreness), VACCINATION SITE SWELLING (had a raised area that was quite large) and FATIGUE (Energy levels have decreased) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was not provided by the reporter Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: TCR: information added which provides 2 new non serious events and patients address
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Wheezing
Clinical narrative: Difficulty Breathing; Wheezing; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty Breathing), WHEEZING (Wheezing) and FATIGUE (Fatigue) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0368A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DYSPNOEA (Difficulty Breathing), WHEEZING (Wheezing) and FATIGUE (Fatigue). On 08-Mar-2021, DYSPNOEA (Difficulty Breathing) and WHEEZING (Wheezing) had resolved. At the time of the report, FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included salbutamol.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm pain lasting 9 days; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Arm pain lasting 9 days) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain lasting 9 days). At the time of the report, PAIN IN EXTREMITY (Arm pain lasting 9 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Itching around the injection site; Redness below injection site/ it got really red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching around the injection site) and VACCINATION SITE ERYTHEMA (Redness below injection site/ it got really red) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness below injection site/ it got really red). On 05-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching around the injection site). On 08-Mar-2021, VACCINATION SITE PRURITUS (Itching around the injection site) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness below injection site/ it got really red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: reactions from 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (reactions from 2nd shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (reactions from 2nd shot). At the time of the report, ADVERSE REACTION (reactions from 2nd shot) outcome was unknown.            No treatment information was provided.  No concomitant medication was provided.    This case was linked to MOD-2021-036492 (E2B Linked Report).; Sender's Comments:  MOD-2021-036492:Cross-linked